Evidence map›Paper›PMID 30708951›Full record

ArticleInternational journal of molecular sciences2019

Cirsiliol Suppressed Epithelial to Mesenchymal Transition in B16F10 Malignant Melanoma Cells through Alteration of the PI3K/Akt/NF-κB Signaling Pathway.

Priyanka Prasad, Andrea Vasas, Judit Hohmann, Anupam Bishayee, Dona Sinha

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. PIK3R2 predicts poor outcomes for patients with melanoma and contributes to the malignant progression via PI3K/AKT/NF-κB axis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Botanical fromEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Inhibition of AURKB, regulated by pseudogeneAmerican journal of cancer research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Priyanka PrasadReceptor Biology and Tumor Metastasis, Chittaranjan National Cancer Institute, Kolkata 700 026, India. pppinki025@gmail.com.
Andrea VasasDepartment of Pharmacognosy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary. vasasa@pharm.u-szeged.hu.
Judit HohmannDepartment of Pharmacognosy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary. hohmann@pharm.u-szeged.hu.ORCID 0000-0002-2887-6392
Anupam BishayeeLake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA. abishayee@lecom.edu.ORCID 0000-0001-9159-960X
Dona SinhaReceptor Biology and Tumor Metastasis, Chittaranjan National Cancer Institute, Kolkata 700 026, India. abishayee@gmail.com.ORCID 0000-0002-9434-2786
Chittaranjan National Cancer Institute · INUniversity of Szeged · HULake Erie College of Osteopathic Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant melanoma is a highly aggressive form of skin cancer which has a propensity for metastasis. Epithelial mesenchymal transition (EMT) plays a primordial role in the progression of metastatic disease. Metastatic melanoma is resistant to conventional therapies. Hence, researchers have been exploring alternative approaches, including the utility of bioactive phytochemicals to manage metastatic disease. In the present study, we investigated the potential of cirsiliol, a flavonoid isolated from

Indexed as

AnimalsCell Line, TumorCell MovementCell SurvivalDose-Response Relationship, DrugEpithelial-Mesenchymal TransitionFlavonesGene Expression Regulation, NeoplasticHumansMelanoma, ExperimentalMiceNF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionSkin NeoplasmscirsiliolFlavonesNF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAktcadherinCentaurea jaceacirsiliolEMTmelanomaMMP-9NF-κBPI3K

Identifiers

PMID30708951
PMCPMC6386903
OpenAlexW2912374207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.